C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2004
11/24/2004	CN1176907C Substituted pyridine herbicides
11/23/2004	US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004	US6822098 Carbocyclic carbo, oxo amines such as n-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders
11/23/2004	US6821992 Fungicides
11/23/2004	US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004	US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004	US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004	US6821976 S-6-hydroxy-buspirone
11/23/2004	US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004	US6821966 Antiinflammatory agents
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2223634C Preparation of n-substituted 3-hydroxypyrazoles
11/23/2004	CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/21/2004	CA2467386A1 Triarylsilyl(meth)acryloyl-containing polymers for marine coating compositions
11/18/2004	WO2004099340A1 Luminescent-polymer composition
11/18/2004	WO2004099201A1 Compounds as crf1 receptor antagonists
11/18/2004	WO2004099192A2 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099187A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
11/18/2004	WO2004099186A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
11/18/2004	WO2004099185A1 2-cyanopyrrolidine derivatives and their use as dpp-iv inhibitors
11/18/2004	WO2004099184A1 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
11/18/2004	WO2004099183A1 Novel polymorphs of pantoprazole sodium
11/18/2004	WO2004099182A1 Zinc salt of (s)-omeprazole
11/18/2004	WO2004099181A1 Barium salt of benzimidazole derivative
11/18/2004	WO2004099180A1 Novel piperidine derivatives
11/18/2004	WO2004099179A1 Piperazine-alkyl-ureido derivatives
11/18/2004	WO2004099178A1 Chemical compounds
11/18/2004	WO2004099177A1 Substituted-1-phthalazinamines as vr-1 antagonists
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099170A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099162A1 Polycyclic diazodioxide-based bcl-2 protein antagonist
11/18/2004	WO2004099161A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004	WO2004099160A1 Pyrimidine compounds and pests controlling composition containing the same
11/18/2004	WO2004099159A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	WO2004099157A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	WO2004099156A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004099155A2 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004	WO2004099154A2 Pyrazole-amides and sulfonamides as sodium channel modulators
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099144A1 Chemical compounds
11/18/2004	WO2004099131A2 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/18/2004	WO2004099130A2 1,2-diarylimidazoles useful as inhibitors of cox
11/18/2004	WO2004098607A1 Pyridinyl acetonitriles
11/18/2004	WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098528A2 Pyrazole-amine compounds useful as kinase inhibitors
11/18/2004	WO2004098518A2 Pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004074246A3 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/18/2004	WO2004054515A3 Thrombopoietin mimetics
11/18/2004	US20040230072 Phosphodiesterase 4 inhibitors
11/18/2004	US20040230057 Dye for optical recording medium
11/18/2004	US20040229937 diaryl ureas, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for treating hyper-proliferative and angiogenesis disorders, as a sole agent or in combination with cytotoxic therapies.
11/18/2004	US20040229927 Imidazole derivatives for treatment of allergic and hyperproliferative disorders
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229917 Imidazole derivatives
11/18/2004	US20040229916 substituted N-(indole-2-carbonyl)amides; antiischemic, anticholesterol, hypoglycemic, hypotensive agents; 5-chloro-1H-indole-2-carboxylic acid-[5-(1,2-dihydroxy-1-methyl-ethyl)-3-ethoxy-pyridin-2-yl]-amide
11/18/2004	US20040229909 Antiviral agent
11/18/2004	US20040229907 2-Aminoquinolinecarboxamides: neurokinin receptor ligands
11/18/2004	US20040229896 Stable pharmaceutical compositions of desloratadine
11/18/2004	US20040229892 HIV integrase inhibitors
11/18/2004	US20040229891 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
11/18/2004	US20040229889 HDAC inhibitor
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229880 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury
11/18/2004	US20040229876 Quinoline derivatives and quinazoline derivatives having azolyl group
11/18/2004	US20040229875 Administering compounds such as 4-(2-Amino-5-phenyl-pyrimidin-4-yl)-1H-pyrrole-2-carboxylic acid dimethylamide for therapy of transplant rejection, melanoma, or a cancer selected from colon, breast, lung, kidney, ovary, pancreas, CNS, or cancer of the gastric tract
11/18/2004	US20040229874 5HT7 Antagonists and inverse agonists
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229868 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229863 Administering 4-amino-azepan-3-one compound for inhibiting cathepsin S
11/18/2004	US20040229861 CGRP receptor antagonists
11/18/2004	US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004	US20040229859 Beta-amino acid compounds as integrin antagonists
11/18/2004	US20040229858 VLA-4 inhibitor compounds
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	US20040228854 Novel chemical substance having morphogenetic and growth-accelerating activities
11/18/2004	CA2531869A1 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna
11/18/2004	CA2525325A1 Pyrazole-amides and sulfonamides as sodium channel modulators
11/18/2004	CA2525195A1 Pyrazinones as crf1 receptor antagonists for the treatment of cns disorders
11/18/2004	CA2524889A1 1,2-diarylimidazoles useful as inhibitors of cox
11/18/2004	CA2524622A1 Substituted-1-phthalazinamines as vr-1 antagonists
11/18/2004	CA2524519A1 Compounds as crf1 receptor antagonists
11/18/2004	CA2524397A1 Cannabinoid receptor ligands and uses thereof
11/18/2004	CA2524321A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	CA2524318A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524235A1 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2524221A1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
11/18/2004	CA2524161A1 Pyridinyl acetonitriles
11/18/2004	CA2523743A1 Heterocycle substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523568A1 Novel piperidine derivatives
11/18/2004	CA2523566A1 Piperazine-alkyl-ureido derivatives
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof

1 ... 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 ... 1080